EnteroTrack
Aurora, US · Founded 2013 · Colorado LLC · 15 employees on LinkedIn
EnteroTrack develops the Esophageal String Test (EnteroTracker), a non-endoscopic, in-office test that measures eosinophil-associated proteins to generate an EoEScore for monitoring Eosinophilic Esophagitis (EoE). The device serves gastroenterologists and allergists as a surveillance tool that correlates with biopsy eosinophil counts and endoscopic severity.
Founders & leadership
EnteroTrack was founded in 2013 by Robin Shandas.
Reported raises · per SEC filings
Form D private placements$4.9M disclosed across 2 rounds · 2014–2021
▶$4.7MraisedJun 2021 · 1 investors · BiotechnologyRule 506(b)
▶$4.7MraisedJun 2021 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jeffrey HarringtonDirector
- Steven AckermanDirector
- Robin ShandasExecutive Officer, Director
- Glenn FurutaDirector
- Offering amount
- $4.7M
- Amount sold
- $4.7M
- First sale
- May 2021
- Incorporated
- Limited Liability Company, Colorado
- Federal exemptions
- 06b
▶$250KraisedJul 2014 · 1 investors · BiotechnologyRule 506(b)
▶$250KraisedJul 2014 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Steven AckermanDirector
- Robin ShandasDirector
- Glenn FurutaDirector
- Offering amount
- $500K
- Amount sold
- $250K
- Minimum investment
- $250K
- First sale
- May 2014
- Incorporated
- Limited Liability Company, Colorado, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 1
by search overlapCompanies competing with EnteroTrack for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does EnteroTrack do?
- EnteroTrack develops the Esophageal String Test (EnteroTracker), a non-endoscopic, in-office test that measures eosinophil-associated proteins to generate an EoEScore for monitoring Eosinophilic Esophagitis (EoE). The device serves gastroenterologists and allergists as a surveillance tool that correlates with biopsy eosinophil counts and endoscopic severity.
- Who founded EnteroTrack?
- EnteroTrack was founded by Robin Shandas in 2013.
- How much funding has EnteroTrack raised?
- EnteroTrack has disclosed $4.9M raised across 2 rounds.
- Where is EnteroTrack headquartered?
- EnteroTrack is headquartered in Aurora, US.



